Toyobo Co. Ltd. (TYO:3101) is looking to kickstart growth in its business for materials capable of inducing bone and nerve…...
Please subscribe to read the full story.
bone regeneration
Teijin Expands Health Care Operations for Bone and Joint Diseases
Teijin Ltd. (TYO:3401) is taking measures to expand its product lineup for bone and joint diseases, a strategic area in…...
Please subscribe to read the full story.
Toyobo Looks to Leverage Bone Regeneration Devices for Health Care Business
Toyobo Co. Ltd. (TYO:3101) is targeting sales in 2025 of 50 billion yen ($446.086 million) for health care related products,…...
Please subscribe to read the full story.
